autologous, homologous, selected renal cells

Cell therapyexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 2013 (NCT01846715)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • autologous, homologous, selected renal cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01846715Phase 1Apr 1, 2013RegenMedTx
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
RegenMedTxFor profit1112013
1 organizations
Page 1 / 1